Adults ages 18 to 70 who experience episodic migraine may qualify for a clinical research study evaluating an investigational medication for migraine prevention.
Episodic Migraine
Age Range:
18 to 70
Gender:
Male and Female
Location:
Rochester, New York
About the Study
Migraines are a neurological condition that can cause throbbing or pulsating head pain and may be accompanied by symptoms such as nausea, vomiting, sensitivity to light, sensitivity to sound, or aura. For some people, migraine attacks continue even after trying preventive treatment options.
Qualifications
You may be able to join if you:
-Are 18 to 70 years of age
-Have been living with migraine for at least 1 year
-Started having migraine attacks at age 50 or younger
-Have several migraine days each month
-Have tried at least 2 different prescription migraine prevention treatments that did not work well enough for you
-Can tell the difference between your migraine headaches and other types of headaches
FEATURED STUDIES
An upcoming clinical research study is evaluating an investigational treatment designed to help prevent the flu in adults who may […]
An upcoming clinical research study is evaluating an investigational vaccine designed to help prevent illness caused by norovirus in adults […]
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]